Vigonvita Life Sciences Co., Ltd. (02630) released its monthly return for the period ended 31 January 2026, confirming that the total authorized share capital remained at RMB 167,597,800. This comprises 66,677,133 H shares listed on The Stock Exchange of Hong Kong Limited and 100,920,667 unlisted shares, all with a par value of RMB 1 per share.

There were no changes in the number of issued H shares or unlisted shares compared with the preceding month. The total number of issued H shares remains 66,677,133, while the number of unlisted shares stands at 100,920,667. The company also confirmed compliance with the applicable 25% minimum public float requirement for its H shares.